Children with Neurodevelopmental Disorders and Disabilities: a Population-based Study of Healthcare Service Utilization Using Administrative Data
Overview
Affiliations
Aim: The aim of this study was to identify children with neurodevelopmental disorders and disabilities (NDD/D) and compare their healthcare service utilization to children without NDD/D using provincial linked administrative data.
Method: The sample included children aged 6 to 10 years (n=183 041), who were registered with the British Columbia Medical Services Plan. Diagnostic information was used for the identification and classification of NDD/D in six functional domains. Healthcare service utilization included outcomes based on physician claims, prescription medication use, and hospitalization.
Results: Overall, 8.3% of children were identified with NDD/D. Children with NDD/D had higher healthcare service utilization rates than those without NDD/D. Effect sizes were: very large for the number of days a prescription medication was dispensed; large for the number of prescriptions; medium for the number of physician visits, different specialists visited, number of different prescription medications, and ever hospitalized; and small for the number of laboratory visits, X-ray visits, and number of days hospitalized.
Interpretation: The findings have policy implications for service and resource planning. Given the high use of psychostimulants, specialized services for both NDD/D and psychiatric conditions may be the most needed services for children with NDD/D. Future studies may examine patterns of physician behaviours and costs attributable to healthcare service utilization for children with NDD/D.
What This Paper Adds: Children with neurodevelopmental disorders and disabilities (NDD/D) have higher healthcare service utilization than those without. Based on provincial population-based linked administrative health data, a sizeable number of children are living with NDD/D. Given the high use of psychostimulants, specialized services for children with both NDD/D and psychiatric conditions may be the most needed services for children with NDD/D.
Shmueli D, Razi T, Almog M, Menashe I, Mimouni Bloch A JAMA Netw Open. 2025; 8(2):e2459029.
PMID: 39928334 PMC: 11811789. DOI: 10.1001/jamanetworkopen.2024.59029.
Kristensen R, Andersen P, Bilenberg N, Milling E, Dalgaard Guldager J BMJ Open. 2025; 15(1):e088850.
PMID: 39819944 PMC: 11751781. DOI: 10.1136/bmjopen-2024-088850.
Fisher A, Gies L, Weber S, Froehlich T, Abimosleh S, Ravindran N Front Pediatr. 2024; 12:1446852.
PMID: 39664285 PMC: 11631611. DOI: 10.3389/fped.2024.1446852.
Thanh N, Eubank B, Waye A, Werle J, Walker R, Hart D Br J Pain. 2024; :20494637241298246.
PMID: 39544406 PMC: 11559509. DOI: 10.1177/20494637241298246.
Cancer chemotherapy in pregnancy and adverse pediatric outcomes: a population-based cohort study.
Metcalfe A, Cairncross Z, McMorris C, Friedenreich C, Nelson G, Bhatti P J Natl Cancer Inst. 2024; 117(3):554-561.
PMID: 39475425 PMC: 11884850. DOI: 10.1093/jnci/djae273.